April 2016

People with type 1 diabetes are three times more prone to the risk of developing epilepsy later in life, finds a new research.The findings revealed that in patients with type 1 diabetes, the risk of developing epilepsy a neurological disorder was significantly higher than that in patients without the disease.

The AYUSH healthcare system is the key to a healthy population, union minister Shripad Naik said on Friday."The goal of achieving a healthy population can be met through AYUSH (Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy) system," the minister of state for AYUSH and health and family welfare said.

The National Human Rights Commission on Friday issued notices to the commerce and health ministries over reports that India has reassured the US-India Business Council to take a restrained approach in handing out licences to produce cheaper versions of drugs patented with the American firms.

The British Medical Journal (BMJ) in its latest issue has called for radical reforms of the Medical Council of India (MCI) which, it said, failed to oversee quality and integrity in health services in the country.

Corbus Pharmaceuticals Holdings Inc. announced that a protocol amendment has been added to one of the Company's existing Investigational New Drug ("IND") Application with the U.S. Food and Drug Administration ("FDA") for a Phase 2 clinical trial of Resunab in systemic lupus erythematosus ("SLE").

AstraZeneca and its global biologics research and development arm, MedImmune, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the conditional approval of Pandemic Live Attenuated Influenza Vaccine (P/LAIV). P/LAIV is indicated for the prevention of influenza in an officially declared pandemic in children and adolescents from 12 months to less than 18 years of age.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo)  announced that the company has filed an application for the manufacture and sales in Japan of hydromorphone hydrochloride oral formulation (extended-release and immediate-release formulations), a narcotic analgesic.